SRTA (Strata Critical Medical, Inc.) Stock Financials & Earnings

SRTAStrata Critical Medical, Inc.

Mkt Cap$410M

Revenue (TTM)$197M

Net Income (TTM)$41M

EPS (TTM)-$0.23

Free Cash Flow (TTM)-$60M

Gross Margin20.9%

Op. Margin-11.3%

Net Margin21.0%

FCF Margin-30.3%

P/S Ratio (TTM)2.1x

P/E Ratio (TTM)9.9x

YoY Rev Growth-20.7%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$45M	$7M	-$13M
Q2 23	$61M	$10M	-$12M
Q3 23	$71M	$16M	-$7M
Q4 23	$47M	$9M	-$36M
Q1 24	$52M	$10M	-$10M
Q2 24	$68M	$16M	-$12M
Q3 24	$75M	$20M	-$4M
Q4 24	$54M	$13M	-$8M
Q1 25	$54M	$12M	-$8M
Q2 25	$71M	$18M	-$5M
Q3 25	$49M	$12M	-$6M
Q4 25	$23M	-$203K	-$4M

Valuation

Operating Cash Flow

Capital Expenditures

CapEx

OpEx vs Revenue Growth (YoY)

Stock-Based Compensation

OpEx Breakdown

Quarter	R&D	G&A	S&M	SG&A
Q1 23	$1M	$16M	$3M	—
Q2 23	$1M	$18M	$3M	—
Q3 23	$1M	$19M	$3M	—
Q4 23	$988K	$41M	$2M	—
Q1 24	$670K	$17M	$2M	—
Q2 24	$971K	$25M	$2M	—
Q3 24	$800K	$20M	$2M	—
Q4 24	$743K	$19M	$1M	—
Q1 25	$812K	$17M	$1M	—
Q2 25	$915K	$20M	$2M	—
Q3 25	$453K	$11M	$482K	—
Q4 25	—	—	—	$19M

Revenue Segments

Revenue by Geography

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$42M	$135M	$177M
Q2 23	$37M	$132M	$170M
Q3 23	$37M	$136M	$173M
Q4 23	$28M	$138M	$166M
Q1 24	$37M	$114M	$151M
Q2 24	$26M	$116M	$142M
Q3 24	$20M	$116M	$136M
Q4 24	$18M	$109M	$127M
Q1 25	$35M	$85M	$120M
Q2 25	$59M	$55M	$113M
Q3 25	$23M	$53M	$76M
Q4 25	$31M	$30M	$61M

Shares Outstanding

Revenue Per Employee

Revenue / Employee